117 related articles for article (PubMed ID: 8262272)
1. [A study with diagnostic standard of occult hyperprolactinemia (OHP) and the effect of bromocriptine administration].
Aisaka K; Kaneda S; Tsuzuki H; Toriya Y; Kokuho K; Tamechika S; Saitoh H; Yoshida K; Mori H
Nihon Naibunpi Gakkai Zasshi; 1993 Oct; 69(9):1017-27. PubMed ID: 8262272
[TBL] [Abstract][Full Text] [Related]
2. [The effect of occult hyperprolactinemia (OHP) on gonadotropin secretion system].
Aisaka K; Yoshida K; Kayama F; Kimura Y; Tamechika S; Satoh K; Matsuoka R; Mori H
Nihon Naibunpi Gakkai Zasshi; 1994 Dec; 70(10):1101-14. PubMed ID: 7859890
[TBL] [Abstract][Full Text] [Related]
3. [Role of TRH or metoclopramide loading test in the diagnosis of so-called occult or latent hyperprolactinemia].
Aisaka K; Ando S; Kokuho K; Kaneda S; Tawada T; Yoshida K; Mori H
Nihon Naibunpi Gakkai Zasshi; 1987 Jul; 63(7):853-61. PubMed ID: 3119381
[TBL] [Abstract][Full Text] [Related]
4. Analysis of clinical backgrounds and pathogenesis of luteal-phase defect.
Aisaka K; Yoshida K; Mori H
Horm Res; 1992; 37 Suppl 1():41-7. PubMed ID: 1427628
[TBL] [Abstract][Full Text] [Related]
5. [Studies on prolactin secreting capacity in the ovulatory infertile patients with transient hyperprolactinemia].
Aisaka K; Ando S; Kokubo K; Yoshida K; Mori H
Nihon Naibunpi Gakkai Zasshi; 1986 May; 62(5):662-71. PubMed ID: 3089848
[TBL] [Abstract][Full Text] [Related]
6. [Effects of transient or occult hyperprolactinemia on luteal function].
Aisaka K; Ando S; Kokubo K; Yoshida K; Mori H
Nihon Naibunpi Gakkai Zasshi; 1986 Feb; 62(2):117-25. PubMed ID: 3084307
[TBL] [Abstract][Full Text] [Related]
7. Occult hyperprolactinemia in infertile women.
Asukai K; Uemura T; Minaguchi H
Fertil Steril; 1993 Sep; 60(3):423-7. PubMed ID: 8375520
[TBL] [Abstract][Full Text] [Related]
8. [Correlation of prolactin-secreting-capacity to circadian profile of prolactin in euprolactinemic women with ovulatory disturbances].
Mori H; Aisaka K; Matsuoka R; Kigawa T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Feb; 37(2):287-92. PubMed ID: 3919123
[TBL] [Abstract][Full Text] [Related]
9. [Correlation of LH and prolactin pulses in normoprolactinemic women with ovulatory disturbances and variation of LH and FSH pulses and secreting capacity by administration of bromocriptine in the same cases].
Kato K; Watanabe R; Ito E; Sakamoto T; Morishima M; Hoshino K; Tanaka M; Tadokoro N
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Dec; 38(12):2241-50. PubMed ID: 3100705
[TBL] [Abstract][Full Text] [Related]
10. [Study on hyperprolactinemic anovulatory syndrome and treatment with bromocriptine (author's transl)].
Fukunaga T
Acta Obstet Gynaecol Jpn; 1981 Feb; 33(2):229-38. PubMed ID: 7015779
[TBL] [Abstract][Full Text] [Related]
11. [Effects of bromocriptine on FSH and LH secretion in women with euprolactinemic anovulation (author's transl)].
Mori H; Aisaka K; Kigawa T; Minakuchi H; Sakamoto S
Nihon Sanka Fujinka Gakkai Zasshi; 1981 Oct; 33(10):1741-8. PubMed ID: 6796631
[TBL] [Abstract][Full Text] [Related]
12. [The mechanism of induction of ovulation by bromocriptine in euprolactinemic anovulation--the role of occult hyperprolactinemia in anovulation].
Mori H; Aisaka K; Matsuoka R; Kigawa T
Nihon Naibunpi Gakkai Zasshi; 1985 Jan; 61(1):38-47. PubMed ID: 3996685
[TBL] [Abstract][Full Text] [Related]
13. Transient hyperprolactinemia in infertile women with luteal phase deficiency.
Huang KE; Bonfiglio TA; Muechler EK
Obstet Gynecol; 1991 Oct; 78(4):651-5. PubMed ID: 1923170
[TBL] [Abstract][Full Text] [Related]
14. [Comprehensive approach to clinical background and effect of bromocriptine administration in patients with endocrinological polycystic ovarian disease].
Aisaka K; Kaneda S; Tsuzuki H; Tawada T; Kokuho K; Toriya Y; Nojima M; Yoshida K; Mori H
Nihon Naibunpi Gakkai Zasshi; 1990 Feb; 66(2):101-12. PubMed ID: 2332079
[TBL] [Abstract][Full Text] [Related]
15. Hypogonadism, galactorrhoea and hyper-prolactinaemia: Evaluation of pituitary gonadotrophins reserve before and under bromocriptine.
Asfour M; L'Hermite M; Hedouin-Quincampoix M; Fossati P
Acta Endocrinol (Copenh); 1977 Apr; 84(4):738-49. PubMed ID: 322432
[TBL] [Abstract][Full Text] [Related]
16. [The effects of bromocriptine on anovulatory patients with high LH and euprolactinemia].
Mori H; Aisaka K; Matsuoka R; Kigawa T
Nihon Naibunpi Gakkai Zasshi; 1985 Jan; 61(1):48-55. PubMed ID: 3922814
[TBL] [Abstract][Full Text] [Related]
17. Luteal phase hyperprolactinemia.
Falk RJ; Anderson L
Int J Fertil Menopausal Stud; 1994; 39(5):272-7. PubMed ID: 7820160
[TBL] [Abstract][Full Text] [Related]
18. Evidence for an altered luteinizing hormone sensitivity to naloxone in pathological hyperprolactinaemia.
Larrea F; Sandoval JL; Salinas E; Franco-Rodriguez VA; Méndez I; Ulloa-Aguirre A
Clin Endocrinol (Oxf); 1995 Nov; 43(5):591-600. PubMed ID: 8548944
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of vaginal bromocriptine in treating women with hyperprolactinemia.
Kletzky OA; Vermesh M
Fertil Steril; 1989 Feb; 51(2):269-72. PubMed ID: 2912773
[TBL] [Abstract][Full Text] [Related]
20. Prolactin response to thyrotropin-releasing hormone in normoprolactinemic patients with ovulatory dysfunction and its use for selection of candidates for bromocriptine therapy.
Steinberger E; Nader S; Rodriguez-Rigau L; Ayala C; Smith K
J Endocrinol Invest; 1990 Sep; 13(8):637-42. PubMed ID: 2148756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
